FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Cysteamine Hydrochloride Ophthalmic Solution
Status: Currently in Shortage
»Date first posted: 10/27/2020
»Therapeutic Categories: Ophthalmology

Leadiant Biosciences, Inc. (Revised 12/21/2020)

Company Contact Information:

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
0.44%, 15 mL bottle (NDC 54482-020-01) In shortage; Estimated shortage duration: Unknown Delay in manufacturing. For more information please contact 1-866-634-2765, Leadiant@tmac.com, or go to www.leadiant.com Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English